Suppr超能文献

紧急优先移植:何时应进行?

Urgent priority transplantation: when should it be done?

作者信息

Stevenson L W, Donohue B C, Tillisch J H, Schulman B, Dracup K A, Laks H

机构信息

Division of Cardiology, UCLA Medical Center 90024-1679.

出版信息

J Heart Transplant. 1987 Sep-Oct;6(5):267-72.

PMID:3316550
Abstract

The success of heart transplantation has created longer waiting lists of candidates, some of whom require transplantation urgently. Decisions must be made regarding which patients require urgent transplantation and how many donor hearts should be committed to urgent transplantation. To determine whether some patients who are considered refractory to medical therapy may be stabilized for elective transplantation, 40 patients transferred for urgent transplantation underwent intensive vasodilator and diuretic therapy, and outcomes were determined. To examine the impact of urgent transplantation on survival, we then determined the survival for urgent priority candidates in the western region. Discharge of the patients who were receiving oral dosages of vasodilators and diuretics was possible for 32 of 40 patients (80%), with a 6-month actuarial survival of 75% on medical therapy, despite an initial ejection fraction of 0.15 +/- 0.04, a cardiac index of 1.9 +/- 0.6 L/min/m2, and a pulmonary wedge pressure of 30 +/- 8 mm Hg. Of 11 patients discharged to await regular priority transplantation, one died suddenly, one died postoperatively, and the others went home 14 +/- 4 days after transplantation. The eight patients unable to be discharged after transfer had lower initial mean arterial pressures and serum sodium levels. Of 59 urgent priority patients from the five western region programs, 50 patients underwent transplantation after 33 +/- 41 days. Subsequent 1-month survival was 88% and overall survival 80%, compared with 97% and 90% in 137 regular priority patients, with a 4.5 times greater risk of early mortality in the urgent group (p = 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

心脏移植的成功导致等待移植的候选者名单越来越长,其中一些人急需进行移植。必须做出关于哪些患者需要紧急移植以及应分配多少供体心脏用于紧急移植的决策。为了确定一些被认为对药物治疗无效的患者是否可以通过强化治疗稳定下来以便进行择期移植,40名因紧急移植而转诊的患者接受了强化血管扩张剂和利尿剂治疗,并确定了治疗结果。为了研究紧急移植对生存率的影响,我们随后确定了西部地区紧急优先候选者的生存率。40名接受口服血管扩张剂和利尿剂治疗的患者中,有32名(80%)可以出院,尽管其初始射血分数为0.15±0.04、心脏指数为1.9±0.6L/min/m²、肺楔压为30±8mmHg,但接受药物治疗的6个月实际生存率仍为75%。在11名出院等待常规优先移植的患者中,1人突然死亡,1人术后死亡,其他患者在移植后14±4天回家。转诊后无法出院的8名患者初始平均动脉压和血清钠水平较低。在来自西部地区五个项目的59名紧急优先患者中,50名患者在33±41天后接受了移植。随后的1个月生存率为88%,总体生存率为80%,而137名常规优先患者的这两个数字分别为97%和90%,紧急组早期死亡风险高4.5倍(p = 0.02)。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验